Recent advances in first-line treatment of metastatic colorectal cancer

被引：0
|
作者：
Fakih, Marwan [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
COLORECTAL CANCER | 2012年 / 1卷 / 02期
关键词：
D O I：
10.2217/CRC.12.12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：111 / 114
页数：4
相关论文
共 50 条
  • [41] Addition of Bevacizumab to First-Line Chemotherapy for Metastatic Colorectal Cancer
    Tsutsumi, Soichi
    Fujii, Takaaki
    Yamaguchi, Satoru
    Suto, Toshinaga
    Yajima, Reina
    Morita, Hiroki
    Kato, Toshihide
    Asao, Takayuki
    Kuwano, Hiroyuki
    HEPATO-GASTROENTEROLOGY, 2014, 61 (131) : 633 - 637
  • [42] Recent advances for the treatment of pancreatic and biliary tract cancer after first-line treatment failure
    Onesti, Concetta Elisa
    Romiti, Adriana
    Roberto, Michela
    Falcone, Rosa
    Marchetti, Paolo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (10) : 1183 - 1198
  • [43] Triplet combination of fluoropyrimidines, oxaliplatin, and irinotecan in the first-line treatment of metastatic colorectal cancer
    Masi, Gianluca
    Vasile, Enrico
    Loupakis, Fotios
    Bursi, Simona
    Ricci, Sergio
    Petrini, Iacopo
    Fontana, Andrea
    Allegrini, Giacomo
    Falcone, Alfredo
    CLINICAL COLORECTAL CANCER, 2008, 7 (01) : 7 - 14
  • [44] FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancer
    Loupakis, F.
    Cremolini, C.
    Salvatore, L.
    Masi, G.
    Sensi, E.
    Schirripa, M.
    Michelucci, A.
    Pfanner, E.
    Brunetti, I.
    Lupi, C.
    Antoniotti, C.
    Bergamo, F.
    Lonardi, S.
    Zagonel, V.
    Simi, P.
    Fontanini, G.
    Falcone, A.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (01) : 57 - 63
  • [45] ECONOMIC EVALUATION OF THE USE OF CAPECITABINE AS FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER IN MEXICO
    Lechuga, D.
    Alva, M.
    Leyva, V
    Salinas, G. E.
    VALUE IN HEALTH, 2012, 15 (04) : A222 - A223
  • [46] Efficacy of apatinib combined with FOLFIRI in the first-line treatment of patients with metastatic colorectal cancer
    Xuetong Rong
    Haiyi Liu
    Hongmei Yu
    Jian Zhao
    Jie Wang
    Yusheng Wang
    Investigational New Drugs, 2022, 40 : 340 - 348
  • [47] Reply: Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
    J Feliu
    J Barriuso
    British Journal of Cancer, 2011, 104 : 226 - 226
  • [48] Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study
    Antonuzzo, Lorenzo
    Giommoni, Elisa
    Pastorelli, Davide
    Latiano, Tiziana
    Pavese, Ida
    Azzarello, Domenico
    Aieta, Michele
    Pastina, Ilaria
    Di Fabio, Francesca
    Bertolini, Alessandro
    Corsi, Domenico Cristiano
    Mogavero, Selene
    Angelini, Valentina
    Pazzagli, Mario
    Di Costanzo, Francesco
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (23) : 7281 - 7288
  • [49] Efficacy of apatinib combined with FOLFIRI in the first-line treatment of patients with metastatic colorectal cancer
    Rong, Xuetong
    Liu, Haiyi
    Yu, Hongmei
    Zhao, Jian
    Wang, Jie
    Wang, Yusheng
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (02) : 340 - 348
  • [50] Comment on ‘Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer’
    M J Molina-Garrido
    C Guillén-Ponce
    British Journal of Cancer, 2011, 104 : 224 - 225
12345